Palisade Bio, Inc. - Common Stock (PALI)

Palisade Bio Inc is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs in the field of gastrointestinal health

The company specializes in the advancement of its proprietary drug candidates aimed at improving patient outcomes, particularly in surgery-related settings and conditions affecting the digestive system. By leveraging its expertise in drug formulation and delivery, Palisade Bio seeks to enhance the safety and effectiveness of treatments, ultimately striving to enhance the quality of life for patients dealing with complex gastrointestinal disorders.